Abstract | BACKGROUND: A 2010 nationwide survey of plastic and reconstructive surgeons indicated that approximately 83 percent performed predominantly implant-based breast reconstruction, with acellular dermal matrix used by approximately half of those practitioners. Although the medical literature documents well over 2000 cases of breast reconstruction with matrices, relatively few cases using other than human cadaveric acellular dermal matrices have been reported. The author compared complications and costs using SurgiMend fetal bovine and AlloDerm human cadaveric acellular dermal matrices. METHODS: A retrospective review of a single surgeon's 5-year experience was performed for consecutive, nonrandomized immediate breast reconstructions with acellular dermal matrix from 2005 to 2010. RESULTS: CONCLUSIONS: CLINICAL QUESTION/LEVEL OF EVIDENCE: : Therapeutic, III.
|
Authors | Jennifer L Butterfield |
Journal | Plastic and reconstructive surgery
(Plast Reconstr Surg)
Vol. 131
Issue 5
Pg. 940-951
(May 2013)
ISSN: 1529-4242 [Electronic] United States |
PMID | 23629076
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
|
Topics |
- Acellular Dermis
- Adult
- Animals
- Breast Implants
(economics)
- Breast Neoplasms
(economics, surgery)
- Cadaver
- Cattle
- Collagen
(therapeutic use)
- Female
- Hospital Costs
(statistics & numerical data)
- Humans
- Mammaplasty
(economics, methods)
- Middle Aged
- Postoperative Complications
(economics, prevention & control)
- Retrospective Studies
- Tissue Expansion Devices
(economics)
- Treatment Outcome
|